Glutaredoxin 3 promotes migration and invasion via the Notch signalling pathway in oral squamous cell carcinoma

References

• Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–178.
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Scott CD, Leonardi AJ, et al. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. J Clin Invest. 2016;126(1):318–334.
   PubMed Web of Science ®Google Scholar
• Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome. Immunol Rev. 2011;243(1):152–162.
   PubMed Web of Science ®Google Scholar
• Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, ‘Amplifiers or an Achilles’ heel? Nat Rev Cancer. 2014;14(11):709–721.
   PubMed Web of Science ®Google Scholar
• Blaser H, Dostert C, Mak TW, et al. TNF and ROS Crosstalk in inflammation. Trends Cell Biol. 2016;26(4):249–261.
   PubMed Web of Science ®Google Scholar
• Ludin A, Gur-Cohen S, Golan K, et al. Reactive oxygen species regulate hematopoietic stem cell selfrenewal, migration and development, as well as their bone marrow microenvironment. Antioxid Redox Signal. 2014;21(11):1605–1619.
   PubMed Web of Science ®Google Scholar
• Nogueira V, Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res. 2013;19(16):4309–4314.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Q, Zhou L, et al. Cancer drug resistance: redox resetting renders a way. Oncotarget. 2016;7(27):42740–42761.
   PubMedGoogle Scholar
• Reinbothe TM, Ivarsson R, Li DQ, et al. Glutaredoxin-1 mediates NADPH-dependent stimulation of calcium-dependent insulin secretion. Mol Endocrinol. 2009;23(6):893–900.
   PubMedGoogle Scholar
• Aslund F, Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell. 1999;96(6):751–753.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wang J, Ray PS, et al. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. J Clin Invest. 2011;121(1):212–225.
   PubMed Web of Science ®Google Scholar
• Witte S, Villalba M, Bi K, et al. Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain. J Biol Chem. 2000;275(3):1902–1909.
   PubMed Web of Science ®Google Scholar
• Lillig CH, Berndt C, Holmgren A. Glutaredoxin systems. Biochim Biophys Acta. 2008;1780(11):1304–1317.
   PubMed Web of Science ®Google Scholar
• Cha H, Kim JM, Oh JG, et al. PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J Mol Cell Cardiol. 2008;45(6):796–803.
   PubMed Web of Science ®Google Scholar
• He F, Wei L, Luo W, et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget. 2016;7(24):37000–37012.
   PubMedGoogle Scholar
• Lu Y, Zhao X, Luo G, et al. Thioredoxin-like protein 2b facilitates colon cancer cell proliferation and inhibits apoptosis via NF-κB pathway. Cancer Lett. 2015;363(2):119–126.
   PubMed Web of Science ®Google Scholar
• Wang SS, Jiang J, Liang XH, et al. Links between cancer stem cells and epithelial-mesenchymal transition. OncoTargets Ther. 2015;8:2973–2980.
   PubMed Web of Science ®Google Scholar
• Kim RK, Kaushik N, Suh Y, et al. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer. Oncotarget. 2016;7(33):53430–53442.
   PubMedGoogle Scholar
• Lu Y, Zhao X, Li K, et al. Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran. Antioxid Redox Signal. 2013;19(9):899–911.
   PubMed Web of Science ®Google Scholar
• Pham K, Pal R, Qu Y, et al. Nuclear glutaredoxin 3 is critical for protection against oxidative stress-induced cell death. Free Radic Biol Med. 2015;85:197–206.
   PubMed Web of Science ®Google Scholar
• Hanschmann EM, Godoy JR, Berndt C, et al. Thioredoxins, glutaredoxins, and peroxiredoxins – molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal. 2013;19(13):1539–1605.
   PubMed Web of Science ®Google Scholar
• He ZJ, Zhu FY, Li SS, et al. Inhibiting ROS-NF-κB-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma. Food Chem Toxicol. 2017;101:55–66.
   PubMed Web of Science ®Google Scholar
• Maehata Y, Ozawa S, Kobayashi K, et al. Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells. Free Radic Res. 2010;44(8):913–924.
   PubMed Web of Science ®Google Scholar
• Alpay M, Backman LR, Cheng X, et al. Oxidative stress shapes breast cancer phenotype through chronic activation of ATM-dependent signaling. Breast Cancer Res Treat. 2015;151(1):75–87.
   PubMed Web of Science ®Google Scholar
• Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163(3):560–569.
   PubMed Web of Science ®Google Scholar
• Jayavelu AK, Müller JP, Bauer R, et al. NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells. Leukemia. 2016;30(2):473–483.
   PubMed Web of Science ®Google Scholar
• Sorce S, Nuvolone M, Keller A, et al. The role of the NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathog. 2014;10(12):e1004531.
   PubMed Web of Science ®Google Scholar
• da Silva Augusto L, Moretti NS, Ramos TC, et al. A membrane-bound eIF2 alpha kinase located in endosomes is regulated by heme and controls differentiation and ROS levels in Trypanosoma cruzi. PLoS Pathog. 2015;11(2):e1004618.
   PubMed Web of Science ®Google Scholar
• Wang G, Yao J, Li Z, et al. miR-34a-5p inhibition alleviates intestinal ischemia/reperfusion-induced reactive oxygen species accumulation and apoptosis via activation of SIRT1 signaling. Antioxid Redox Signal. 2016;24(17):961–973.
   PubMed Web of Science ®Google Scholar
• Yang YJ, Baek JY, Goo J, et al. Effective killing of cancer cells through ROS-mediated mechanisms by AMRI-59 targeting peroxiredoxin I. Antioxid Redox Signal. 2016;24(8):453–469.
   PubMed Web of Science ®Google Scholar
• Fan TF, Wu TF, Bu LL, et al. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma. Oncotarget. 2016;7(37):59691–59703.
   PubMedGoogle Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–591.
   PubMed Web of Science ®Google Scholar
• Okon IS, Coughlan KA, Zhang M, et al. Gefitinib-mediated reactive oxygen species (ROS) instigates mitochondrial dysfunction and drug resistance in lung cancer cells. J Biol Chem. 2015;290(14):9101–9110.
   PubMed Web of Science ®Google Scholar
• Okon IS, Zou MH. Mitochondrial ROS and cancer drug resistance: implications for therapy. Pharmacol Res. 2015;100:170–174.
   PubMed Web of Science ®Google Scholar
• Giannoni E, Parri M, Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid Redox Signal. 2012;16(11):1248–1263.
   PubMed Web of Science ®Google Scholar
• Ye LY, Chen W, Bai XL, et al. Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis. Cancer Res. 2016;76(4):818–830.
   PubMed Web of Science ®Google Scholar
• Brabletz T. To differentiate or not – routes towards metastasis. Nat Rev Cancer. 2012;12(6):425–436.
   PubMed Web of Science ®Google Scholar
• Kato N, Motohashi S, Okada T, et al. PICOT, protein kinase C theta-interacting protein, is a novel regulator of FcepsilonRI-mediated mast cell activation. Cell Immunol. 2008;251(1):62–67.
   PubMed Web of Science ®Google Scholar
• Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284(5415):770–776.
   PubMed Web of Science ®Google Scholar
• Timmerman LA, Grego-Bessa J, Raya A, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18(1):99–115.
   PubMed Web of Science ®Google Scholar
• Zavadil J, Cermak L, Soto-Nieves N, et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004;23(5):1155–1165.
   PubMed Web of Science ®Google Scholar
• Güngör C, Zander H, Effenberger KE, et al. Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. Cancer Res. 2011;71(14):5009–5019.
   PubMed Web of Science ®Google Scholar
• Sun W, Gaykalova DA, Ochs MF, et al. Activation of the NOTCH pathway in head and neck cancer. Cancer Res. 2014;74(4):1091–1104.
   PubMed Web of Science ®Google Scholar
• Weaver AN, Burch MB, Cooper TS, et al. Notch signaling activation is associated with patient mortality and increased FGF1-mediated invasion in squamous cell carcinoma of the oral cavity. Mol Cancer Res. 2016;14(9):883–891.
   PubMed Web of Science ®Google Scholar
• Upadhyay P, Nair S, Kaur E, et al. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget. 2016;7(31):50437–50449.
   PubMedGoogle Scholar
• Liu L, Zhang K, Sandoval H, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160(1–2):177–190.
   PubMed Web of Science ®Google Scholar
• Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48(2):158–167.
   PubMed Web of Science ®Google Scholar